Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.
Year: 1998
Type: article
Source: Journal of Clinical Oncology
Institution: Sapienza University of Rome
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2139401596
